Navarro-Partida, J.; Altamirano-Vallejo, J.C.; Aceves Franco, L.A.; Gonzalez-Cortes, J.; Hernandez-Da Mota, S.; García-Aguirre, J.G.; Azuara-Galindo, C.D.; Castro-Castaneda, C.R.; Armendariz-Borunda, J.; Santos, A.
Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration. Pharmaceutics 2021, 13, 1491.
https://doi.org/10.3390/pharmaceutics13091491
AMA Style
Navarro-Partida J, Altamirano-Vallejo JC, Aceves Franco LA, Gonzalez-Cortes J, Hernandez-Da Mota S, García-Aguirre JG, Azuara-Galindo CD, Castro-Castaneda CR, Armendariz-Borunda J, Santos A.
Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration. Pharmaceutics. 2021; 13(9):1491.
https://doi.org/10.3390/pharmaceutics13091491
Chicago/Turabian Style
Navarro-Partida, Jose, Juan Carlos Altamirano-Vallejo, Luis Abraham Aceves Franco, Jesús Gonzalez-Cortes, Sergio Hernandez-Da Mota, Jose Gerardo García-Aguirre, Carlos David Azuara-Galindo, Carlos Rodrigo Castro-Castaneda, Juan Armendariz-Borunda, and Arturo Santos.
2021. "Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration" Pharmaceutics 13, no. 9: 1491.
https://doi.org/10.3390/pharmaceutics13091491
APA Style
Navarro-Partida, J., Altamirano-Vallejo, J. C., Aceves Franco, L. A., Gonzalez-Cortes, J., Hernandez-Da Mota, S., García-Aguirre, J. G., Azuara-Galindo, C. D., Castro-Castaneda, C. R., Armendariz-Borunda, J., & Santos, A.
(2021). Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration. Pharmaceutics, 13(9), 1491.
https://doi.org/10.3390/pharmaceutics13091491